Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticoagulants for stroke prevention in nonvalvular atrial fibrillation: new agents and an updated understanding.

Literature DB >> 22949768

Anticoagulants for stroke prevention in nonvalvular atrial fibrillation: new agents and an updated understanding.

Abstract

Entities: Disease

Keywords: Antiarrhythmic agents; apixaban; aspirin; atrial fibrillation; dabigatran etexilate; factor Xa/antagonists & inhibitors; fibrinolytic agents; stroke/prevention & control; warfarin

Mesh：

Substances：
Anticoagulants

Year: 2012 PMID： 22949768 PMCID： PMC3423272

Source DB: PubMed Journal: Tex Heart Inst J ISSN： 0730-2347

Keyword Cloud
References

× No keyword cloud information.

28 in total

1. Rivaroxaban in patients with a recent acute coronary syndrome.

Authors: Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal: N Engl J Med Date: 2011-11-13 Impact factor: 91.245

2. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome.

Authors: C Michael Gibson; Jessica L Mega; Paul Burton; Shinya Goto; Freek Verheugt; Christoph Bode; Alexei Plotnikov; Xiang Sun; Nancy Cook-Bruns; Eugene Braunwald
Journal: Am Heart J Date: 2011-05 Impact factor: 4.749

3. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.

Authors: Rangadham Nagarakanti; Michael D Ezekowitz; Jonas Oldgren; Sean Yang; Michael Chernick; Timothy H Aikens; Greg Flaker; Josep Brugada; Gabriel Kamensky; Amit Parekh; Paul A Reilly; Salim Yusuf; Stuart J Connolly
Journal: Circulation Date: 2011-01-03 Impact factor: 29.690

4. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors: B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal: JAMA Date: 2001-06-13 Impact factor: 56.272

5. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].

Authors: Da-yi Hu; He-ping Zhang; Yi-hong Sun; Li-qing Jiang
Journal: Zhonghua Xin Xue Guan Bing Za Zhi Date: 2006-04

6. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Authors: Antonio L Dans; Stuart J Connolly; Lars Wallentin; Sean Yang; Juliet Nakamya; Martina Brueckmann; Michael Ezekowitz; Jonas Oldgren; John W Eikelboom; Paul A Reilly; Salim Yusuf
Journal: Circulation Date: 2012-12-27 Impact factor: 29.690

7. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.

Authors: Gregory Y H Lip; Lars Frison; Jonathan L Halperin; Deirdre A Lane
Journal: Stroke Date: 2010-10-21 Impact factor: 7.914